View Document Preview and Link Document Date: 2001-06-18 18:00:00 Open Document File Size: 20,02 KB Share Result on Facebook
City San Francisco / Rahway / New York / Dakar / / Company Merck & Co. Inc. / Merck & Company / Pfizer / GlaxoSmithKline / Merck / New Lexington Press / / Continent Europe / / Country Senegal / Yemen / Central African Republic / Benin / Uganda / Burkina Faso / Togo / Tanzania / Ghana / / Facility University of Notre Dame Press / Whitehouse Station / / IndustryTerm healthcare objectives / health services / healthcare infrastructures / healthcare personnel / healthcare workers / healthcare infrastructure / healthcare system / regular healthcare delivery / / MedicalCondition river blindness / onchocerciasis / dreadful disease / illness / blindness / cataracts / disease / lymphatic filariasis / diseases / infection / intense itching / Roy Vagelos Attacks River Blindness / / MusicGroup the World / the WHO / / Organization World Health Organization / University of Notre Dame Press / United Nations International Children's Emergency Fund / MECTIZAN Expert Committee / American Management Association / World Bank / for Us All / / Person David Bollier / Michael G. Pratt / Santé / Michael Useem / Jane E. Dutton / Lee A. Tavis / Parasitology / Jeffrey L. Sturchio / Lynda St. Clair / Andrew R. McGill / Raymond V. Gilmartin / / Position chairman / Director / Public Affairs Human Health / Executive Director / Public Affairs / Private / / Product MECTIZAN tablets / vitamin A / / ProvinceOrState New Jersey / Indiana / / Region West Africa / Middle East / Latin America / / SocialTag 
The Case of Ivermectin: Lessons Learned and Implications for Improving Access to Care and Treatment in Developing Countries Jeffrey L. Sturchio, Ph.D. Executive Director, Public Affairs